Under construction – not a live service
Sign in
Taking people in United StatesNo phase

Brain mapping study for people with epilepsy undergoing intracranial monitoring

Tests a brain mapping method in adults with partial epilepsy.

Plain-language title generated from the registry record
Registry title: Intracranial Stimulation Mapping In Epilepsy

Key facts

Where
Minneapolis, United StatesSee the site

Where in United States

  • University of MinnesotaMinneapolis, United StatesTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
University of Minnesota
Trial code
NCT05290610
Record updated
9 April 2026
Original description
This is a single group prospective study to determine the feasibility for generating brain maps that localize cerebral functions and inter-regional information flow in partial epilepsy in adult patients.Read full original descriptionShow less

Intracranial Stimulation Mapping In Epilepsy -The InStim Study

This is a single group prospective study to determine the feasibility for generating brain maps that localize cerebral functions and inter-regional information flow in partial epilepsy in adult patients.

Inclusion: Male or female 18 years and older at screening; Written informed consent is obtained from the participant to comply with the requirements of the study; Stated willingness to comply with all study procedures and availability for the duration of the study; Currently undergoing clinically indicated intracranial EEG monitoring for planning of epilepsy surgery in the University of Minnesota/MINCEP program.

Exclusion: Pregnancy ruled out prior to approval for intracranial EG monitoring; Persons who are rendered temporarily or permanently invulnerable by inability to understand the research due to study complexity, cognitive impairment, or by inability to make independent decisions owing to University of Minnesota or to Fairview health services.

ClinicalTrials.gov NCT05290610